Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pons

Showing results (371-380 of 394) with videos related to

Pageof 40
Sort By:
Annals of the Rheumatic Diseases|January 28, 2014
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsR Cervera, R Serrano, G J Pons-Estel, et al.
Lupus|September 11, 2024
Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patientsGuillermo J Pons-Estel, Rosana Quintana, Manuel F Ugarte-Gil, et al.
Clinical Rheumatology|June 27, 2022
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary dataCarolina A Isnardi, Emilce E Schneeberger, Jennifer L Kreimer, et al.
Lupus|February 9, 2024
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohortRomina Nieto, Rosana Quintana, Ernesto Zavala-Flores, et al.
The Lancet. Rheumatology|June 15, 2024
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countriesEleana Bolla, Anne Grete Semb, Anne M Kerola, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 1, 2022
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry)Carolina Ayelen Isnardi, Enrique R Soriano, Cesar Graf, et al.
RMD Open|December 14, 2020
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)Cristina Reátegui-Sokolova, Manuel F Ugarte-Gil, Guillermina B Harvey, et al.
Lupus Science & Medicine|April 10, 2026
Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data networkFederico Zazzetti, Ashley Orillion, Urbano Sbarigia, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Lupus|February 25, 2026
Protective effect of antimalarials on the most frequently affected damage domains in SLE: Data from a multiethnic Latin American cohortRosana Quintana, Guillermo J Pons-Estel, Daniel Wojdyla, et al.
Pageof 40

Showing results (371-380 of 394) with videos related to

Sort By:
Pageof 40
Annals of the Rheumatic Diseases|January 28, 2014
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsR Cervera, R Serrano, G J Pons-Estel, et al.
Lupus|September 11, 2024
Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patientsGuillermo J Pons-Estel, Rosana Quintana, Manuel F Ugarte-Gil, et al.
Clinical Rheumatology|June 27, 2022
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary dataCarolina A Isnardi, Emilce E Schneeberger, Jennifer L Kreimer, et al.
Lupus|February 9, 2024
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohortRomina Nieto, Rosana Quintana, Ernesto Zavala-Flores, et al.
The Lancet. Rheumatology|June 15, 2024
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countriesEleana Bolla, Anne Grete Semb, Anne M Kerola, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 1, 2022
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry)Carolina Ayelen Isnardi, Enrique R Soriano, Cesar Graf, et al.
RMD Open|December 14, 2020
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)Cristina Reátegui-Sokolova, Manuel F Ugarte-Gil, Guillermina B Harvey, et al.
Lupus Science & Medicine|April 10, 2026
Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data networkFederico Zazzetti, Ashley Orillion, Urbano Sbarigia, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Lupus|February 25, 2026
Protective effect of antimalarials on the most frequently affected damage domains in SLE: Data from a multiethnic Latin American cohortRosana Quintana, Guillermo J Pons-Estel, Daniel Wojdyla, et al.
Pageof 40